FDA Approved: ADDYI — Supplemental Application (Sprout Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ADDYI (flibanserin) filed by Sprout Pharmaceuticals, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• ADDYI (flibanserin)

Snippet

SUPPL AP for ADDYI (FLIBANSERIN)